ELUT: Elutia Inc Long-Term Debt Volume

Graphic logo of Elutia Corporation (ELUT)

Elutia Inc. (ELUT) generates revenue from the creation of biomedical devices, including high-margin antimicrobial coatings and orthopedic grafts. The asset's market dynamics on GURU.Markets show a value of 0.00. Successes with the CanGaroo shell and new FDA approvals are driving the company's growth. Meanwhile, management is currently optimizing internal processes following the implementation of bioplatforms, maintaining shareholder confidence through expansion in the bioprosthetics segment.

ELUT Elutia Inc.: Company Long-Term Debts in the range 02/21/2024 - 10/29/2026

Analytical breakdowns for Elutia Inc.

- price and consensus price forecast:
Share Price elutia.com|ELUT - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Elutia|ELUT - Enterprise Value
- book capitalization data:
Accounting Value per Share Elutia|ELUT - Book Capitalization|Market Capitalization to Book Value Ratio elutia.com|ELUT - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Elutia Inc.|ELUT - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Elutia Corporation|ELUT - Company Aggregate Debts|Debts to Net Assets Elutia|ELUT - Company Long-Term Debt|Company Short-Term Indebtedness Elutia
General company analysis:elutia.com (ELUT)
Mass-produced product of Elutia Corporation

For Elutia Inc. (ELUT), a leader in anti-infective implants with premium pricing power, the company's long-term debt statistics reflect its innovation financing strategy. This indicator aggregates all liabilities with maturities exceeding one year, allowing for an assessment of the debt load without accounting for quarterly lags, where excessive growth in the loan portfolio could offset high operating margins and reduce the overall resilience of the asset.

Competitor analysis

Company Long-Term Indebtedness intuitive.com ISRG|Company Long-Term Debts DHR (Danaher)|BDX - Long-Term Debt Volume|STE (STERIS Corporation) - Company Long-Term Debts|West Pharma Corp (WST) - Company Long-Term Liabilities|BAX (Baxter International) - Company Long-Term Debts|Company Long-Term Debts MASI|Company Long-Term Debt Stevanato Group (STVN)|Company Long-Term Debt Teleflex Inc. TFX|Company Long-Term Liabilities Merit Medical Systems Inc|Company Long-Term Loans and Borrowings Nobel Biocare NVST|Company Long-Term Debts ICUI (ICU Medical, Inc.)|XRAY: Long-Term Debt Volume|Company Long-Term Debt LeMaitre Vascular|ATRC (AtriCure Inc) - Company Long-Term Indebtedness|STAA: Company Long-Term Debt|Long-Term Debt Volume niagenbioscience.com (NAGE)|Company Long-Term Liabilities ZimVie Inc.|Amount of Long-Term Liabilities ANGO (angiodynamics.com)|Company Long-Term Debt Cerus|TKNO - Company Long-Term Loans and Borrowings|Monogram Technologies Inc - Company Long-Term Liabilities|STSS: Company Long-Term Debts|INFU (infusystem.com) - Company Long-Term Debt|utahmed.com (UTMD) - Company Long-Term Liabilities|Company Long-Term Debts KRMD (KORU Medical Systems, Inc.)|Long-Term Debt NYXH|Company Long-Term Debt Microbot Medical Inc MBOT|Company Long-Term Indebtedness Pro-Dex Inc. PDEX|Company Long-Term Liabilities Zentek Ltd. (ZTEK)|milestonescientific.com - Amount of Long-Term Liabilities|Company Long-Term Debt NXGL (NEXGEL)|RVP - Long-Term Debt Volume|Company Long-Term Debts HBIO|FEMY (Femasys Corporation) - Long-Term Debt|Company Long-Term Debt Meihua Medical Technologies|Company Long-Term Debt Predictive Oncology Corp (POAI)|Company Long-Term Liabilities CJMB|Company Long-Term Debts Atrion Corp. ATRI|Company Long-Term Liabilities NeuroMetrix Corp (NURO)